Fremanezumab for the Preventive Treatment of Chronic Migraine. [PDF]
New England Journal of Medicine, 2017 BACKGROUND: Fremanezumab, a humanized monoclonal antibody targeting calcitonin gene-related peptide (CGRP), is being investigated as a preventive treatment for migraine.
Aycardi, Ernesto +9 more
core +4 more sources
NeuroImage: Clinical, 2023 Acute withdrawal of headache medication in chronic migraine patients with medication overuse may lead to a dramatic reduction in headache frequency and severity.
Veronica Mäki-Marttunen +8 more
doaj +1 more source
The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine [PDF]
, 2018 Migraine remains one of the biggest clinical case to be solved among the non-communicable diseases, second to low back pain for disability caused as reported by the Global Burden of Disease Study 2016.
Martelletti, Paolo
core +1 more source
Characteristic oscillatory brain networks for predicting patients with chronic migraine
The Journal of Headache and Pain, 2023 To determine specific resting-state network patterns underlying alterations in chronic migraine, we employed oscillatory connectivity and machine learning techniques to distinguish patients with chronic migraine from healthy controls and patients with ...
Fu-Jung Hsiao +8 more
doaj +1 more source
Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification. [PDF]
, 2009 There is evidence that the prevalence of migraine in children and adolescents may be increasing. Current theories of migraine pathophysiology in adults suggest activation of central cortical and brainstem pathways in conjunction with the peripheral ...
A Ferrari +52 more
core +1 more source
New players in the preventive treatment of migraine. [PDF]
, 2015 Migraine is a common, chronic disorder of the brain causing much disability, as well as personal, familial and societal impact. Several oral preventive agents are available in different countries for the prevention of migraine, but none have performed ...
Mitsikostas, Dimos D, Rapoport, Alan M
core +3 more sources
Correlation of vestibular symptoms and headache in migraine patients: a clinical study of 424 cases
Di-san junyi daxue xuebao, 2021 Objective To evaluate the correlation between vestibular symptoms and headache in patients with migraine, and to explore the diagnostic value of vestibular symptoms in migraine.
LIU Juan +6 more
doaj +1 more source
Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series. [PDF]
, 2016 BACKGROUND: Refractory migraine is a challenging condition with great impact on health related quality of life. Intravenous (IV) ketamine has been previously used to treat various refractory pain conditions.
Ashina, Sait +3 more
core +3 more sources
Induction of chronic migraine phenotypes in a rat model after environmental irritant exposure [PDF]
, 2017 Air pollution is linked to increased emergency department visits for headache and migraine patients frequently cite chemicals or odors as headache triggers, but the association between air pollutants and headache is not well understood.
Hurley, Joyce Harts +4 more
core +1 more source
Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety
Toxins, 2015 Background: Chronic migraine is a common, highly disabling, underdiagnosed and undertreated entity of migraine. It affects 0.9%–2.2% of the general adult population.
Délia Szok +3 more
doaj +1 more source